Sectorial report (Health) : A United States Federal Court found that payments made by Schering Plough in order to delay the introduction of generic forms of its drugs did not violate Antitrust Law, in a 26 March 2010 decision.

You have already subscribed

• Manage your subscription

Settings updated

Thank you

A confirmation email has been sent. Please click on the confirmation link inside to finish your subscription

Code sent

An email has been sent with a code. Please click on the link inside to access the settings page

Unregistered